Long-term prognostic and predictive factors in 107 stage II/III breast cancer patients treated with anthracycline-based neoadjuvant chemotherapy (Q36431766)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Long-term prognostic and predictive factors in 107 stage II/III breast cancer patients treated with anthracycline-based neoadjuvant chemotherapy	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

14 August 2017

Long-term prognostic and predictive factors in 107 stage II/III breast cancer patients treated with anthracycline-based neoadjuvant chemotherapy (English)

1 reference

Europe PubMed Central

14 August 2017

author name string

Brain E

1

1 reference

Europe PubMed Central

14 August 2017

Garrino C

2

1 reference

Europe PubMed Central

14 August 2017

Misset JL

3

1 reference

Europe PubMed Central

14 August 2017

Carbonero IG

4

1 reference

Europe PubMed Central

14 August 2017

Itzhaki M

5

1 reference

Europe PubMed Central

14 August 2017

Cvitkovic E

6

1 reference

Europe PubMed Central

14 August 2017

Goldschmidt E

7

1 reference

Europe PubMed Central

14 August 2017

Burki F

8

1 reference

Europe PubMed Central

14 August 2017

Regensberg C

9

1 reference

Europe PubMed Central

14 August 2017

Pappo E

10

1 reference

Europe PubMed Central

14 August 2017

Hagipantelli R

11

1 reference

Europe PubMed Central

14 August 2017

Musset M

12

1 reference

Europe PubMed Central

14 August 2017

language of work or name

0 references

publication date

1 January 1997

1 reference

Europe PubMed Central

14 August 2017

British Journal of Cancer

1 reference

Europe PubMed Central

14 August 2017

75

1 reference

Europe PubMed Central

14 August 2017

9

1 reference

Europe PubMed Central

14 August 2017

1360-1367

1 reference

Europe PubMed Central

14 August 2017

https://scigraph.springernature.com/pub.10.1038/bjc.1997.230

0 references

Efficacy of up-front 5-fluorouracil-epidoxorubicin-cyclophosphamide (FEC) chemotherapy with an increased dose of epidoxorubicin in high-risk breast cancer patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2228243

30 September 2017

Reporting results of cancer treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2228243

30 September 2017

Evaluation of survival data and two new rank order statistics arising in its consideration

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2228243

30 September 2017

Pathological assessment of response to induction chemotherapy in breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2228243

30 September 2017

Management of stage III primary breast cancer with primary chemotherapy, surgery, and radiation therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2228243

30 September 2017

Primary chemotherapy to avoid mastectomy in tumors with diameters of three centimeters or more

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2228243

30 September 2017

Recent data provided by fine needle aspiration of the breast

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2228243

30 September 2017

Evolving concepts in the systemic adjuvant treatment of breast cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2228243

30 September 2017

Combined chemotherapy-radiotherapy approach in locally advanced (T3b-T4) breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2228243

30 September 2017

Adjuvant chemo- and hormonal therapy in locally advanced breast cancer: a randomized clinical study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2228243

28 June 2018

Primary medical therapy for operable breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2228243

28 June 2018

Prognostic factors in locally advanced noninflammatory breast cancer. Long-term results following primary chemotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2228243

28 June 2018

Results of neoadjuvant chemotherapy and radiation therapy in the breast-conserving treatment of 250 patients with all stages of infiltrative breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2228243

28 June 2018

Effects of primary chemotherapy in conservative treatment of breast cancer patients with operable tumors larger than 3 cm. Results of a randomized trial in a single centre

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2228243

28 June 2018

Phase II study of tetrahydropyranyl adriamycin (pirarubicin) in elderly patients with advanced breast cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2228243

28 June 2018

Natural history and survival of inoperable breast cancer treated with radiotherapy and radiotherapy followed by radical mastectomy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2228243

28 June 2018

Adjuvant treatment of node-positive breast cancer with cyclophosphamide, doxorubicin, fluorouracil, and vincristine versus cyclophosphamide, methotrexate, and fluorouracil: final report after a 16-year median follow-up duration.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2228243

21 September 2018

Sequential cytopunctures during preoperative chemotherapy for primary breast carcinoma. Cytomorphologic changes, initial tumor ploidy, and tumor regression

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2228243

21 September 2018

Pathologic predictors of early local recurrence in stage I and II breast cancer treated by primary radiation therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/9155059

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Primary chemotherapy in the treatment of inflammatory breast carcinoma: a study of 230 cases from the Institut Gustave-Roussy

1 reference

https://pubmed.ncbi.nlm.nih.gov/9155059

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neoadjuvant chemotherapy in the combined modality approach of locally advanced nonmetastatic breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/9155059

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Results of initial doxorubicin, 5-fluorouracil, and cyclophosphamide combination chemotherapy for inflammatory carcinoma of the breast

1 reference

https://pubmed.ncbi.nlm.nih.gov/9155059

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Impact of axillary lymph node dissection on the therapy of breast cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/9155059

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Induction chemotherapy followed by breast conservation for locally advanced carcinoma of the breast

1 reference

https://pubmed.ncbi.nlm.nih.gov/9155059

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Primary (neoadjuvant) chemotherapy and radiotherapy compared with primary radiotherapy alone in stage IIb-IIIa breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/9155059

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High complete remission rates with primary neoadjuvant infusional chemotherapy for large early breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/9155059

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preoperative chemotherapy: a model for studying the biology and therapy of primary breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/9155059

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/BJC.1997.230

1 reference

Europe PubMed Central

14 August 2017

1 reference

Europe PubMed Central

14 August 2017

1 reference

Europe PubMed Central

14 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36431766&oldid=1518678465"